Folicum

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Folicum

What is Folicum?

Folicum is a medicinal preparation of folic acid, a water-soluble vitamin belonging to the B-complex group. It is a synthetic form of folate, which occurs naturally in various foods. Folic acid is an essential nutrient required for several fundamental biological processes within the human body.

Primary Function and Biological Role

The active component in Folicum plays a critical role in the synthesis of nucleic acids, including DNA and RNA. By facilitating these genetic building blocks, it supports the production and maintenance of new cells. This function is particularly vital during periods of rapid cell division and growth.

Folicum is also involved in the formation of red blood cells. It acts as a coenzyme in the synthesis of heme, the iron-containing portion of hemoglobin, which allows red blood cells to transport oxygen throughout the body.

Therapeutic Use

Folicum is primarily used to address states where folate levels are insufficient to meet the body's physiological demands. These states generally fall into two categories:

  • Deficiency Treatment: It is used to manage confirmed folate deficiencies, which may arise from inadequate dietary intake, malabsorption issues in the digestive tract, or certain chronic conditions that deplete vitamin stores.
  • Prevention of Neural Tube Defects: Because of its role in DNA synthesis and cell growth, folate is necessary for the proper development of the fetal central nervous system. Folicum is often utilized prior to and during the early stages of pregnancy to support the healthy formation of the neural tube.

Mechanisms of Action

Once ingested, the folic acid in Folicum is converted by the body into tetrahydrofolate. This active metabolite serves as a donor of one-carbon units in various metabolic reactions, including the conversion of homocysteine to methionine. Maintaining appropriate levels of these amino acids is essential for cellular metabolism and overall biochemical balance.

Regulatory References

  1. WHO Essential Medicines List
  2. NIH ODS Folate Fact Sheet

What side effects are possible with Folicum?

Possible Side Effects and Safety Information

The safety profile of Folicum (folic acid) is generally well-established. Adverse reactions are rare at standard recommended doses, but certain precautions and clinically significant risks must be considered.

Adverse Reactions

Adverse effects are generally mild, uncommon, and may involve the following system-organ classes:

  • Gastrointestinal Disturbances: Nausea, loss of appetite, bloating, or flatulence.
  • Skin and Immune System: Skin rash, itching, redness, or other signs of allergic reaction.
  • Central Nervous System: Irritability, trouble sleeping, or confusion (particularly with higher doses).

Serious Adverse Reactions: The most serious, though very rare, risk is a severe allergic reaction (anaphylaxis), which can present as difficulty breathing, swelling of the face, lips, tongue, or throat, or hives, and requires immediate medical attention.

Safety Restrictions and Monitoring

1. Vitamin B12 Deficiency Masking (Major Safety Risk):

Folic acid supplementation, particularly in doses exceeding 0.4 mg to 1 mg daily, may improve the anaemia (blood count) associated with a Vitamin B12 deficiency (e.g., pernicious anaemia), but it will not stop the progression of irreversible neurological damage caused by the B12 deficiency. Treatment of megaloblastic anaemia must always involve ruling out or co-treating any underlying B12 deficiency to prevent permanent nerve damage.

2. Drug and Condition Interactions:

  • Seizure Disorders: High doses of folic acid may potentially increase the frequency of seizures or lower the effectiveness of certain anti-epileptic medications (such as phenytoin, primidone, or phenobarbital), potentially requiring an adjustment of the anticonvulsant dose.
  • Other Medications: Folic acid can interact with other medicines, including some antibiotics and certain cancer treatments (e.g., methotrexate), which may affect the efficacy or toxicity of either substance.
  • Prior Cancer: Patients with a history of certain cancers should use high-dose folic acid with caution and under medical guidance.

3. Dosing Safety Limits:

The established tolerable upper intake level (UL) for folic acid in adults is 1 mg (1,000 mcg) per day, primarily due to the risk of masking B12 deficiency. Doses above 1 mg have been associated with increased non-serious side effects like gastrointestinal upset and irritability.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents classify Folicum (Folic Acid) as relatively nontoxic in man, stating that acute overdosage is unlikely to cause harm. Consequently, no specific antidote is known, and no special procedures are typically needed for acute ingestion. Management remains symptomatic and supportive.

Documented Manifestations and Emergency Action

Classification Specific Regulatory Statement
Toxicity Profile Classified as low acute toxicity. Manifestations like nausea, confusion, or altered sleep patterns are linked to chronic, high-dose ingestion over time.
Life-Threatening Risk Rare instances of severe allergic responses, including respiratory difficulty due to bronchospasm or symptoms suggesting anaphylaxis, have been documented.
Emergency Action Immediate medical attention must be sought if signs of a severe allergic response or respiratory distress are observed.
Specific Risk High intake may dangerously mask the progression of neurologic damage in patients with undiagnosed B12 deficiency, even as blood cell metrics normalize.

Therapeutic Uses of Folicum

Folic acid, the synthetic form of the B-vitamin folate (Vitamin B9), generally plays a role in supporting functional stability, which is why it is applied across domains where additional symptomatic support is needed.


Main Uses and Benefits of Folicum

The primary therapeutic areas for folic acid (Folicum) are relevant in contexts involving heightened systemic burden and addressing states of systemic imbalance. A main use is applied in addressing symptoms related to systemic imbalance, a condition characterized by periods of heightened symptoms such as weakness, fatigue, and symptoms that interfere with daily functioning. By playing a role in managing systemic imbalance, Folicum helps ease the overall symptom burden and supports general well-being.

This substance is commonly used to help with certain conditions including addressing symptoms of systemic imbalance, managing symptomatic burden in chronic hemolytic states, and is relevant in contexts involving heightened systemic burden during symptomatic periods. This is considered relevant in clinical settings that involve acute or unstable symptom patterns. It supports the patient during difficult episodes by easing distress and is commonly used when short-term symptomatic assistance is needed.

Its relevance extends to conditions characterized by periods of heightened symptoms in contexts where increased physiological requirements are a factor. It is considered relevant to assist with functional stability in situations involving certain distressing symptoms.

Quick Fact: Supports Easing of Symptoms that Interfere with Daily Functioning

Regulatory References

  1. NIH MedlinePlus overview of Folic Acid

Eligibility and Restrictions for Use

Who Can and Cannot Use Folicum?

The population eligibility for Folicum (Folic Acid) is defined by regulatory documents, which establish specific conditions for use and absolute prohibitions. The medicine is generally permitted for use by most adults, children, and adolescents under standard labeled conditions.

Folicum is specifically allowed and often recommended for women who are capable of becoming pregnant, during pregnancy, and while breastfeeding, as Folic Acid is an essential nutrient.

Contraindications and Restrictions

Folicum must not be used (contraindicated) in patients with a known hypersensitivity to the active substance or excipients. A critical prohibition applies to individuals with pernicious anaemia or any undiagnosed megaloblastic anaemia; use in these patients is contraindicated because the medicine may mask the symptoms of underlying Vitamin B12 deficiency.

Regulatory labeling also restricts use in patients with malignant disease/cancer, unless the patient has confirmed megaloblastic anaemia caused by folic acid deficiency. Use requires caution in individuals who may have folate-dependent tumors. Patients with rare hereditary metabolic disorders are also advised against using the formulation due to tablet excipients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Folicum (Folic Acid) documents several clinically significant interactions with other medicinal products and certain substances. These interactions are classified as either pharmacokinetic (altering drug exposure) or pharmacodynamic (altering drug activity).


Interaction Type Interacting Agents Official Outcome Description
Pharmacokinetic Phenytoin, Phenobarbital, Primidone Folic Acid can decrease the serum concentration of these antiepileptics, a mutual interaction where these agents also reduce Folic Acid exposure.
Pharmacodynamic Methotrexate, Pyrimethamine, Trimethoprim Folic Acid may mutually inhibit the intended therapeutic effects of these antifolate agents.
Drug-Substance Alcohol (ethanol) Officially noted to interfere with folate metabolism and impair its absorption, reducing systemic exposure.

Pharmacokinetic and Exposure Alterations

The regulatory information states that Folic Acid may accelerate the metabolism of specific anticonvulsant medicines, which formally results in a decrease in the anticonvulsant's plasma concentration. This mutual pharmacokinetic interaction is further confirmed by the documented effect that these anticonvulsants also reduce the body's absorption and increase the clearance of Folic Acid itself.

Antagonistic Effects and Substance Constraints

A clear pharmacodynamic constraint exists with antifolate medicines, where Folic Acid may reduce their effectiveness. Additionally, the antibiotic Chloramphenicol is documented to hinder the desired hematological response to Folic Acid treatment. The consumption of Alcohol is officially noted to interfere with the metabolism and absorption of folate.

Mechanism of Action

How Folicum Works: Mechanism of Action

Core Mechanistic Role as a Metabolic Cofactor

Folicum (Folic Acid) functions as an inactive precursor that is actively transported into cells and processed by enzymes, including MTHFR, to become the active cofactor, 5-methyl-THF. This molecule serves as the necessary substrate for fundamental metabolic processes, initiating critical enzymatic cascades.

Pathway Modulation and Cellular Synthesis

The active folate cofactor is essential for One-Carbon (1C) Metabolism. It directly supports the production of purines and thymidylate, which are components required for the synthesis and repair of DNA and RNA. This mechanism is necessary for the progression of replication and maturation processes of high-turnover cells, particularly those involved in blood formation.

Methionine Cycle and Homocysteine Regulation

Folicum's mechanism is key to the Methionine/Homocysteine Cycle. The active cofactor acts as a methyl-donor to convert the amino acid homocysteine back into methionine. This results in a reduction of plasma homocysteine concentrations and the production of S-adenosylmethionine (SAMe), which is vital for widespread cellular methylation reactions that control gene expression and maintenance of cellular integrity.

Dosage and Administration Information

How Folicum is Used: Official Administration Guidelines

Folicum, which contains the active ingredient Folic Acid, is administered according to specific regimens. These instructions define the routes, dosage, and duration of administration.


Official Administration and Dosing

Administration Component Regulatory Instruction
Route of Administration Primarily Oral (tablet). Parenteral routes (Intramuscular, Intravenous, or Subcutaneous) are approved alternatives for cases involving severe deficiency or malabsorption.
Standard Adult Dose Typically 1 mg daily for treatment of deficiency, with a higher therapeutic dose of 5 mg daily common in many regions. Doses up to 15 mg daily may be necessary for malabsorption states.
Dosing Frequency Administration is generally once daily. Continuous use may be prescribed for chronic conditions.
Intake Conditions The tablet should be swallowed whole with water and may be taken with or without food.

Population-Specific Use and Duration

Official labels detail specific rules for certain patient groups:

  • Pediatric Patients: Dosage is determined by age, body weight, and severity, with typical therapeutic doses ranging from 0.1 mg to 1 mg daily for children.
  • High-Risk Prophylaxis: A higher dose of 4 mg to 5 mg daily is specified for individuals at high risk (e.g., prior neural tube defect history) who are planning conception, starting before pregnancy and continuing through the first trimester.

Treatment duration is typically 4 months to correct an existing deficiency, but is managed as a continuous, long-term regimen for prophylaxis in chronic conditions, such as chronic hemolytic states. If a dose is missed, patients are generally instructed to skip the missed dose and resume the regular schedule, without taking two doses to compensate.

Recent Clinical Evidence

Research evidence / Overview of studies for Folicum

This overview summarizes the scientific evidence for Folicum (Folic Acid) described in official regulatory and peer-reviewed scientific literature. The text focuses on the types of studies conducted, the outcomes researchers tracked, and what remains unclear in the evidence base, without offering any clinical recommendations or advice.


Evidence for Addressing Folate-Deficiency Anemia

The evidence for Folicum in cases of confirmed folate deficiency is largely derived from foundational clinical studies. Researchers primarily focused on populations with low folate levels and monitored changes in key hematological parameters such as Hemoglobin (Hb) and Mean Corpuscular Volume (MCV). Findings from this body of work describe patterns in the shifts of these blood markers that are associated with the introduction of the substance. Regulatory bodies highlight that this substance requires careful differentiation from underlying Vitamin B12 deficiency.


Evidence for Pre-Pregnancy and Early Pregnancy Support

The most extensive high-quality evidence, including large, landmark Randomized Controlled Trials (RCTs) and meta-analyses, was studied for Folicum's role in the period before and during the earliest weeks of pregnancy. The studies examined the incidence or risk of Neural Tube Defects (NTDs) in offspring, such as Spina Bifida, and monitored the essential nutrient concentration (Red Blood Cell Folate) as a biomarker. Research consistently describes an association with lower NTD risk in the offspring of women who received supplementation during the periconceptional period.


Research Gaps and Areas of Uncertainty

Despite the long history of use, the evidence base includes several areas of uncertainty. A major gap is the lack of contemporary placebo-controlled trials for established deficiency, as this is now considered unethical due to the known clinical need for the substance. Evidence quality varies across studies, particularly for non-specific symptoms like fatigue, where findings were mixed and often serve as secondary data points. Furthermore, long-term effects are not fully established regarding the health consequences of elevated, unmetabolized levels of Folicum in the blood over decades.

Key Studies & References

  1. WHO Model List of Essential Medicines (Folic acid entry)
  2. NICE Guideline: Sickle cell disease: managing acute and chronic complications (Includes supportive care rationale)

Frequently Asked Questions (FAQ)

Common questions about Folicum (FAQ)


Q: Is Folicum the same as other vitamin supplements?

A: Folicum is classified by regulatory bodies as a water-soluble B-complex vitamin, specifically Vitamin B9. It is also grouped as a hematopoietic agent because its purpose is to supply an essential nutrient required for the fundamental process of blood cell formation.


Q: Why is Folicum described as a 'pro-vitamin'?

A: Official documents often refer to Folicum (Folic Acid) as an inactive precursor. This means the substance itself is not biologically active immediately but must first be converted by specific enzymes inside the body to become the active form that carries out its metabolic functions.


Q: How quickly should I expect to notice any effects from Folicum?

A: Studies examining Folicum's primary therapeutic use have described that a measurable hematological response (changes in blood cell parameters) can be observed within a few weeks of beginning treatment for a deficiency. However, individual patient-perceived effects or the relief of symptoms can vary widely.


Q: Do official documents mention Folicum's effect on hair or skin?

A: Official safety information describes that Folicum may rarely cause adverse effects on the skin, such as rash, itching, or redness, which are typically signs of an allergic reaction. Beyond these specific, adverse events, non-adverse effects on hair or skin health are not generally detailed in the regulatory labeling.


Q: Why are people with certain genetic variations often given Folicum?

A: Official documents describe Folicum (Folic Acid) as an inactive compound that must be processed by specific enzymes in the body, such as MTHFR, to become the active folate needed for metabolism.


Q: What happens if a person accidentally takes too much Folicum?

A: According to regulatory warnings, Folicum has a low risk of acute toxicity, meaning severe harm from a single large dose is uncommon. However, a major safety restriction is that taking excessively high amounts over time increases the risk of masking an undiagnosed Vitamin B12 deficiency. This masking effect can allow irreversible neurological damage to progress unnoticed.


Q: Why is Folicum sometimes discussed in relation to cardiovascular health?

A: The mechanism of Folicum is key to the body's metabolic cycle that converts the substance homocysteine back into methionine. This action results in a reduction of homocysteine levels in the blood. This substance has been a focus of scientific studies examining risk factors in relation to heart health.


Q: Is Folicum generally considered safe for elderly patients?

A: Folicum is generally described for use by the elderly population under standard labeled conditions. Official documents do not typically specify unique risks or dosage adjustments solely based on advanced age, although caution is sometimes advised when severe accompanying health issues are present.


Q: Is Folicum suitable for people with a history of kidney problems?

A: Use in patients with kidney problems is generally addressed in official labeling at the lower doses used for nutritional support and maintenance. Regulatory caution is typically advised in cases of severe renal impairment or when the medicine is prescribed at higher therapeutic doses.


Q: Can Folicum be taken if I have a gluten intolerance or celiac disease?

A: The active ingredient in Folicum is synthetic and not gluten-derived. Official product information states that the final tablet formulation does not typically include gluten-containing substances. Information on the list of excipients (inactive ingredients) is provided in the official packaging documentation for patients with celiac disease or gluten intolerance.


Q: Does taking Folicum require regular blood tests?

A: Regulatory documents strongly emphasize the importance of ruling out Vitamin B12 deficiency before starting Folicum, as the medicine can mask the blood count symptoms of B12 deficiency. This diagnostic step often involves initial blood tests. Routine monitoring for general maintenance use is not usually specified in the label.


Q: Is Folicum suitable for vegans or vegetarians?

A: The suitability of Folicum for vegans or vegetarians depends entirely on the specific excipients (inactive ingredients) used in the tablet formulation, even though the active ingredient is synthetic. The official list of ingredients is available in the product documentation for those following specific diets.


Q: Are there different forms or salts of Folicum available?

A: Official regulatory documents state that Folicum contains the active ingredient Folic Acid, which is chemically identified as Pteroylglutamic acid. The product information identifies this specific chemical structure as the active ingredient in the preparation.


Q: Can Folicum cause dizziness or headaches?

A: While official documents may not explicitly list dizziness or headaches, they do list general Central Nervous System disturbances as potential adverse reactions. These effects can include confusion, irritability, or trouble sleeping, and are sometimes more noticeable when higher doses are used.


Q: Is the absorption of Folicum affected by stomach acid levels?

A: Pharmacokinetic sections in official product information describe that the absorption of Folicum (Folic Acid) from the digestive tract is a pH-dependent process. This means the substance’s absorption relies on the acid levels and processes occurring in the stomach lining.


Q: How long does Folicum stay in the system after the last dose?

A: According to pharmacokinetic information, the active circulating form of the substance is described as having a terminal half-life of several hours. This biological measurement is used to estimate how long the active substance remains in the system after the last dose is taken.

How should Folicum be stored and disposed of?

How to Store and Dispose of Folicum

Folicum (Folic Acid) tablets must be stored according to official regulatory requirements to maintain product stability and safety.

Storage Conditions

Folicum should be stored at controlled room temperature, typically below 25°C or 30°C, as mandated by regulatory labeling. The medicine must be kept in its original container and protected from light and moisture. For safety, it must be stored out of the sight and reach of children.


Disposal Instructions

Unused or expired Folicum must not be thrown away in wastewater or household trash. Official instructions require that the product be returned to a pharmacist for proper pharmaceutical waste disposal to ensure protection of the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Folicum found in:

A-Z Index: